Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02854436
Title An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Acronym Galahad
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | GBR | FRA | ESP | CAN | BEL | AUS

Facility Status City State Zip Country Details
Tucson Arizona United States Details
Los Angeles California United States Details
Riverside California United States Details
Sacramento California United States Details
Aurora Colorado United States Details
Denver Colorado United States Details
Evanston Illinois United States Details
Danville Kentucky United States Details
Louisville Kentucky United States Details
New Orleans Louisiana United States Details
Boston Massachusetts United States Details
Detroit Michigan United States Details
Omaha Nebraska United States Details
New York New York United States Details
Durham North Carolina United States Details
Lancaster Pennsylvania United States Details
Philadelphia Pennsylvania United States Details
Myrtle Beach South Carolina United States Details
Houston Texas United States Details
Charlottesville Virginia United States Details
Fairfax Virginia United States Details
Seattle Washington United States Details
Madison Wisconsin United States Details
Camperdown Australia Details
Darlinghurst Australia Details
East Albury Australia Details
Kurralta Park Australia Details
Macquarie University Australia Details
Melbourne Australia Details
Murdoch Australia Details
Port Macquarie Australia Details
Randwick Australia Details
Wahroonga Australia Details
Aalst Belgium Details
Brussel Belgium Details
Charleroi Belgium Details
Gent Belgium Details
Haine-Saint-Paul, La Louviere Belgium Details
Hasselt Belgium Details
Kortrijk Belgium Details
Liège Belgium Details
Namur Belgium Details
Ottignies Belgium Details
Wilrijk Belgium Details
Barretos Brazil Details
Belo Horizonte Brazil Details
Curitiba Brazil Details
Fortaleza Brazil Details
Ijui Brazil Details
Itajai Brazil Details
Joinville Brazil Details
Natal Brazil Details
Salvador Brazil Details
Sao Paulo Brazil Details
Vancouver British Columbia Canada Details
Oshawa Ontario Canada Details
Toronto Ontario Canada Details
Montreal Quebec Canada Details
Quebec Canada Details
Aarhus N. Denmark Details
Copenhagen N Denmark Details
Herlev Denmark Details
Odense C Denmark Details
Avignon Cedex 9 France Details
Besancon France Details
Caen France Details
Lyon France Details
Nice Cedex 2 France Details
Paris France Details
Reims France Details
Strasbourg France Details
Villejuif Cedex France Details
Beer-Sheva Israel Details
Haifa Israel Details
Kfar Saba Israel Details
Ramat Gan Israel Details
Zrifin Israel Details
Seoul Korea, Republic of Details
Alkmaar Netherlands Details
Amsterdam Netherlands Details
Groningen Netherlands Details
Maastricht Netherlands Details
Rotterdam Netherlands Details
Moscow Russian Federation Details
Omsk Russian Federation Details
Tomsk Russian Federation Details
Barcelona Spain Details
Córdoba Spain Details
Madrid Spain Details
Málaga Spain Details
Pozuelo de Alarcon Spain Details
Santander Spain Details
Santiago de Compostela Spain Details
Sevilla Spain Details
Valencia Spain Details
Göteborg Sweden Details
Lund Sweden Details
Stockholm Sweden Details
Umeå Sweden Details
Kaohsiung Taiwan Details
Taichung Taiwan Details
Tainan Taiwan Details
Taipei Taiwan Details
Taoyuan County Taiwan Details
Blackburn United Kingdom Details
Bristol United Kingdom Details
Cardiff United Kingdom Details
Exeter United Kingdom Details
London United Kingdom Details
Preston United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field